fbpx

News Releases

Lars Oddsson Presents March 6th at ISPRM 2020

March 3, 2020

Walkasins® Co-Inventor Lars Oddsson, PhD Invited to Present at ISPRM 2020 Conference in Orlando

Eden Prairie, Minnesota. (March 2, 2020). Lars Oddsson, Ph.D., co-inventor of Walkasins® and Chief Technology Officer of RxFunction, Inc. has been invited to present at the upcoming ISPRM 2020 14th World Congress being held March 6th – 8th in Orlando, Florida.

The presentation, entitled “New Wearable Sensory Neuroprosthesis for Safer Mobility and Lower Fall-Risk in the Aged Population”, covers interim research related to mobility and fall-risk in subjects with peripheral neuropathy, walk2Wellness, and is part of the “Mobility of the Aged Population” session taking place on March 6th, 2020 at 11:00 am during the Orlando, Florida ISPRM 2020 Conference, found here: ISPRM 2020 Online Schedule.

ISPRM is the International Society of Physical and Rehabilitation Medicine and serves as the global association for Physical and Rehabilitation Medicine (PRM). The 2020 event targeted at physiatrists is co-hosted by the Association of Academic Physiatrists (AAN) and is also their 53rdAnnual Meeting. To learn more about the event, visit ISPRM. RxFunction is exhibiting Walkasins at the congress, booth #431.

The walk2Wellness long-term study is designed to determine the effectiveness of Walkasins, a lower limb sensory neuroprosthesis, in peripheral neuropathy patients at high risk of falling. The study began in late 2018 and is currently underway at five U.S. medical centers. The study is planned to evaluate Walkasins impact on over 100 patients for approximately one year. More information about study site locations, enrollment status, and requirements can be found here.

Walkasins is an external lower limb sensory prosthesis intended to replace the nerve function used for detection and signaling of foot pressure sensation. The company developed Walkasins to help improve balance in patients who experience gait and mobility problems due to sensory peripheral neuropathy, a disorder where the nerves in the feet are damaged causing numbness. Walkasins are available by prescription following evaluation by a trained clinician. According to the National Institutes of Health, an estimated 20 million Americans have some form of peripheral neuropathy, commonly a consequence of diabetes and chemotherapy, and widely present in the elderly population. To learn more about Walkasins, visit www.rxfunction.com.

About RxFunction, Inc. RxFunction™ is a medical device company with a mission to design and market medical technologies that restore balance, increase mobility, and enhance confidence for patients at risk of falling. Privately held and headquartered in Eden Prairie, Minnesota, RxFunction created the Walkasins® lower limb sensory prosthesis, building upon patented technology developed by cofounder and scientist Lars Oddsson, PhD. Development of Walkasins was supported by Small Business Innovation Research grants from the National Institutes of Health (AG040865) and the product is manufactured in Minnesota.

© 2020 RxFunction, Inc. All Rights Reserved. AP-10101v0 0320. Walkasins® and RxFunction™ are trademarks of RxFunction, Inc.